Altered expression of transforming growth factor βs during urethral and bulbourethral gland tumor progression in transgenic mice carrying the androgen-responsive C3(1) 5' flanking region fused to SV40 large T antigen

Carcinogenesis

Volumn 19, Issue 1, 1998, Pages 195-205

  Shibata, Masa Aki ^a,b   Jorcyk, Cheryl L ^a   Devor, Deborah E ^b   Yoshidome, Katsuhide ^a   Rulong, Shen ^b   Resau, James ^b   Roche, Nannette ^a   Roberts, Anita B ^a   Ward, Jerrold M ^b   Green, Jeffrey E ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; ANDROGEN RECEPTOR; PROTEIN P53; RETINOBLASTOMA PROTEIN; TRANSFORMING GROWTH FACTOR BETA; VIRUS LARGE T ANTIGEN;

ADENOCARCINOMA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BULBOURETHRAL GLAND; CONTROLLED STUDY; DNA FLANKING REGION; HORMONAL CARCINOGENESIS; HORMONE RESPONSIVE ELEMENT; MALE; MOUSE; NONHUMAN; ONCOGENE; PRECANCER; PRIORITY JOURNAL; SIMIAN VIRUS 40; TRANSGENIC MOUSE; TUMOR GROWTH; URETHRA CARCINOMA; URETHRA TUMOR;

AGING; ANDROGEN-BINDING PROTEIN; ANIMALS; ANTIGENS, POLYOMAVIRUS TRANSFORMING; BULBOURETHRAL GLANDS; GENITAL NEOPLASMS, MALE; LIVER NEOPLASMS; MALE; MICE; MICE, TRANSGENIC; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; PROTEIN BINDING; RECOMBINANT FUSION PROTEINS; RETINOBLASTOMA PROTEIN; SIMIAN VIRUS 40; TRANSFORMING GROWTH FACTOR BETA; TUMOR SUPPRESSOR PROTEIN P53; URETHRAL NEOPLASMS;

EID: 19244379597     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/19.1.195     Document Type: Article

References (51)

1. Keen, M.R., Golden, R.L., Richardson, J.F. and Melico, M.M. (1970) Carcinoma of Cowper's gland treated with chemotherapy. J. Urol., 104, 854-859.
2. Small, J.D., Albertsen, P.C., Graydon, J., Ricci, A., Jr and Sardella, W.V. (1992) Adenoid cystic carcinoma of Cowper's gland. J. Urol., 147, 699-701.
3. Dodson, M.K., Cliby, W.A., Keeney, G.L., Peterson, M.F. and Podratz, K.C. (1994) Skene's gland adenocarcinoma with increased serum level of prostate-specific antigen. Genecol. Oncol., 55, 304-307.
4. Parker, S.L., Tong, T.A., Bolden, S. and Wingo, P.A. (1996) Cancer statistics. CA Cancer J. Clin., 46, 5-27 [Comment, CA Cancer J. Clin., 46, 3-4, 1996].
5. Parker, S.L., Tong, T.A., Bolden, S. and Wingo, P.A. (1996) Cancer statistics. CA Cancer J. Clin., 46, 5-27 [Comment, CA Cancer J. Clin., 46, 3-4, 1996].
6. Maroulakou, I.G., Anver, M., Garrett, L. and Green, J.E. (1994) Prostate and mammary adenocarcinoma in transgenic mice carrying a rat C3(1) simian virus 40 large tumor antigen fusion gene. Proc. Natl Acad. Sci. USA, 91, 11236-11240.
7. Parker, M.G.R., White, H., Hurst, M., Needham, M. and Tilly, R. (1983) Prostatic steroid-binding protein. Isolation and characterization of C3 genes. J. Biol. Chem., 258, 12-15.
8. Shibata, M-A., Ward, J.M., Devor, D.E., Liu, M.-L. and Green, J.E. (1996) Progression of prostatic intraepithelial neoplasia to invasive carcinoma in C3(1)/SV40 large T antigen transgenic mice: Histopathological and molecular biological alterations. Cancer Res., 56, 4894-4903.
9. Shibata, M.-A., Maroulakou, I.G., Jorcyk, C.L., Gold, L.G., Ward, J.M. and Green, J.E. (1996) p53-independent apoptosis during mammary tumor progression in C3(1)/SV40 large T antigen transgenic mice: Suppression of apoptosis during the transition from preneoplasia to carcinoma. Cancer Res., 56, 2998-3003.
10. Eastham, J.A., Truong, L.D., Rogers, E., Kattan, M., Flanders, K.C., Scardino, P.T. and Thompson, T.C. (1995) Transforming growth factor-β1: Comparative immunohistochemical localization in human primary and metastatic prostate cancer. Lab. Invest., 73, 628-635.
11. Kim, I.Y., Ahn, H.-J., Zelner, D.J., Shaw, J.W., Sensibar, J.A., Kim, J.-H., Kato, M. and Lee, C. (1996) Genetic change in transforming growth factor β (TGFβ) receptor type I gene correlates with insensitivity to TGF-β1 in human prostate cancer cells. Cancer Res., 56, 44-48.
12. Sehgal, I., Baley, P.A. and Thompson, T.C. (1996) Transforming growth factor β1 stimulates contrasting responses in metastatic versus primary mouse prostate cancer-derived cell lines in vitro. Cancer Res., 56, 3359-3365.
13. Humphrey, P.A., Zhu, X., Zamegar, R., Swanson, P.E., Ratliff, T.L., Vollmer, R.T. and Day, M.L. (1995) Hepatocyte growth factor and its receptor (c-Met) in prostatic carcinoma. Am. J. Pathol. 147, 386-396.
14. Pisters, L.L., Troncoso, P., Zhau, H.E., Li, W., von Eschenbach, A.C. and Chung, L.W. (1995) c-Met proto-oncogene expression in benign and malignant human prostate tissues. J. Urol., 154, 293-298.
15. Michalopoulos, G.K. and Zarnegar, R. (1992) Hepatocyte growth factor. Hepatology, 15, 149-155.
16. Liang, T.J., Reid, A.E., Xavier, R., Cardiff, R.D. and Wang, T.C. (1996) Transgenic expression of tpr-met oncogene leads to development of mammary hyperplasia and tumors. J. Clin. Invest., 97, 2872-2877.
17. Natali, P.G., Prat, M., Nicotra, M.R., Bigotti, A., Olivero, M., Comoglio, P.M. and Di Renzo, M.F. (1996) Overexpression of the met/HGF receptor in renal cell carcinomas. Int. J. Cancer (Pred. Oncol.), 69, 212-217.
18. Peehl, D.M. Culture of human prostatic epithelial cells (1992) In Freshney, R.I. (ed.) Culture of Epithelial Cells. Wiley-Liss, New York, pp. 159-180.
19. Shi, S.-R., Key, M.E. and Kalra, K.L. (1991) Antigen retrieval in formalin-fixed, paraffin-embedded tissues: An enhancement method for immunohistochemical staining based on microwave oven heating of tissue sections. J. Histochem. Cytochem., 39, 741-748.
20. Flanders, K.C., Thompson, N.L., Cissel, D.S., Van Obberghen-Schilling, E., Baker, C.C. Kass, M.E., Ellingsworth, L.R., Roberts, A.B. and Sporn, M.B. (1989) Transforming growth factor-β1: histochemical localization with antibodies to different epitopes. J. Cell. Biol., 108, 653-660.
21. Flanders, K.C., Ludecke, G., Engels, S., Cissel, D.S., Roberts, A.B., Kondaiah, P., Lafyatis, R., Sporn, M.B. and Unsicker, K. (1991) Localization and actions of transforming growth factor-βs in the embryonic nervous system. Development, 113, 183-191.
22. Fox, C.H. and Cottler-Fox, M. (1993) In situ hybridization in HIV research. Microsc. Res. Tech., 25, 78-84.
23. Gaspar, M.L., Meo, T. and Tosi, M. (1990) Structure and size distribution of the androgen receptor mRNA in wild-type and Tfm/Y mutant mice. Mol. Endocrinol., 4, 1600-1610.
24. Sabath, D.E., Broome, H.E. and Prystowsky, M.B. (1990) Glyceraldehyde-3-phosphate dehydrogenase mRNA is a major interleukin 2-induced transcript in a cloned T-helper lymphocyte. Gene, 91, 185-191.
25. Hurst, H.C. and Parker, M.G. (1983) Rat prostatic steroid binding protein: DNA sequence and transcript maps of the two C3 genes. EMBO J., 2, 769-774.
26. Green, J.E., Maroulakou, I.G., Shibata, M-A. and Anver, M. (1996) Heterotopic endochondral ossification associated with mixed tumor formation in C3(1)/TAg transgenic mice. Pediatric Res., 39, 59A.
27. Dyson, N., Buchkovich, K., Whyte, P. and Harlow, E. (1989) The cellular 107K protein that binds to adenovirus E1A also associates with the large T antigens of SV40 and JC virus. Cell, 58, 249-255.
28. Mietz, J.A., Unger, T., Huibregtse, J.M. and Howley, P.M. (1992) The transcriptional transactivation function of wild-type p53 is inhibited by SV40 large T-antigen and by HPV-16 E6 oncoprotein. EMBO J., 11, 5013-5020.
29. Zalvide, J. and DeCaprio, J.A. (1995) Role of pRb-related proteins in simian virus 40 large-T-antigen-mediated transformation. Mol. Cell. Biol., 15, 5800-5810.
30. Riley, D.J., Lee, E.Y.-H.P. and Lee, W.H. (1994) The retinoblastoma protein: more than a tumor suppressor. Annu. Rev. Cell Biol., 10, 1-29.
31. Foley, J., Ton, T., Maronpot, R., Butterworth, B. and Goldsworthy, T.L. (1993) Comparison of proliferating cell nuclear antigen to tritiated thymidine as a marker of proliferating hepatocytes in rats. Environ. Hlth Perspect., 101 (Suppl. 5), 199-206.
32. Roberts, A.B. and Sporn, M.B. (1993) Physiological actions and clinical applications of transforming growth factor-β (TGF-β). Growth Factors, 8, 1-9.
33. Sporn, M.B., Roberts, A.B., Wakefield, L.M. and de Crombrugghe, B. (1987) Some recent advances in the chemistry and biology of transforming growth factor β. J. Cell Biol., 105, 1039-1045.
34. Roberts, A.B. and Sporn, M.B. (1990) The transforming growth factor-βs. In Sporn, M.B. and Roberts, A.B. (eds) Peptide Growth Factors and their Receptors. Handbook of Experimental Pharmacology. Springer-Verlag, Heidelberg, pp. 419-472.
35. Samuel, S.K., Hurta, R.A.R., Kondaiah, P., Khalil, N., Turley, E.A., Wright, J.A. and Greenberg A.H. (1992) Autocrine induction of tumor protease production and invasion by a metallothionein-regulated TGF-β1. EMBO J., 11, 1599-1605.
36. Schwarz, L.C., Wright, J.A., Gingras, M.C., Kondaiah, P., Danielpour, D., Pimental, M. and Greenberg, A.H. (1990) Aberrant TGF-β production and regulation in metastatic malignancy. Growth Factor, 3, 115-127.
37. Torre-Amione, G., Beauchamp, R.D., Koeppen, H., Park, B.H., Schreiber, H., Moses, H.L. and Rowley, D.A. (1990) A highly immunogenic tumor transfected with a murine transforming growth factor type β1 cDNA escapes immune surveillance. Proc. Natl Acad. Sci. USA, 87, 1486-1490.
38. Sporn, M.B. and Roberts, A.B. (1985) Autocrine growth factors and cancer. Nature, 313, 745-747.
39. Ellingsworth, J., Schmidt, A., Hall, G., Roberts, A.B. and Sporn, M.B. (1988) Transforming growth factor-β is a potent immunosuppressive agent that inhibits IL-1-dependent lymphocyte proliferation. J. Immunol., 140, 3026-3030.
40. Kehrl, J.H., Wakefield, L.M., Roberts, A.B., Jakowlew, S., Alvarez-Mon, M., Derynck, R., Sporn, M.B. and Fauci, A.S. (1986) Production of transforming growth factor β by human T lymphocytes and its potential role in the regulation of T cell growth. J. Exp. Med., 163, 1037-1050.
41. Steiner, M.S. and Barrack, E.R. (1990) Expression of transforming growth factors and epidermal growth factors in normal and malignant rat prostate. J. Urol., 143, 240A.
42. Merz, V.W., Miller, G.J., Krebs, T., Timme, T.L., Kadmon, D., Park, S.H., Egawa, S., Scardino, P.T. and Thompson, T.C. (1991) Elevated transforming growth factor-β1 and β3 mRNA levels are associated with ras + myc-induced carcinomas in reconstituted mouse prostate: Evidence for a paracrine role during progression. Mol. Endocrinol., 5, 503-513.
43. Truong, L.D., Kadmon, D., McCune, B.K., Flanders, K.C., Scardino, P.T. and Thompson, T.C. (1993) Association of transforming growth factor-β1 with prostate cancer: An immunohistochemical study. Human Pathol., 24, 4-9.
44. Millan, F.A., Kondaiah, P. Denhez, F. and Akhurst, R.J. (1991) Embryonic expression patterns of TGFβ1, 2 and 3 suggest different functions in vivo. Development, 111, 131-144.
45. Cui, W., Fowlis, J., Bryson, S., Duffie, E., Ireland, H., Balmain, A. and Akhurst, J. (1996) TGFβ1 inhibits the formation of benign skin tumors, but enhances progression to invasive spindle carcinomas in transgenic mice. Cell. 86, 531-542.
46. Weidner, K.M., Hartman, G., Sachs, M. and Birchmeier, W. (1993) Properties and functions of scatter factor/hepatocyte growth factor and its receptor c-met. Am. J. Repir. Cell. Mol. Biol. 8, 229-237.
47. Fausto, N. (1991) Hepatocyte growth factor and the c-met oncogene. Hepatology, 14, 738-740.
48. Mann, T. and Lutwak-Mann, C. (1981) Secretory function of the prostate, seminal vessicle, Cowper's Gland and other accessory organs of reproduction. In Mann, T. and Lutwak-Mann, C. (eds) Male Reproductive Function and Semen. Springer-Verlag, Berlin, pp. 171-193.
49. Spring-Mills, E. and Hafez, E.S.E. (1980) The bulbo-urethral glands. In Spring-Mills, E and Hafez, E.S.E. (eds) Male Accessory Sex Glands. Elsevier, North Holland, Amsterdam, pp. 272-278.
50. Nagai, M., Nemoto, T., Masuda, T. and Ota, M. (1995) Reduction of androgen receptor mRNA concentration by testosterone in mouse submandibular gland. Endocr. J., 42, 31-38.
51. Zhau, H.Y.E., Chang, S.-M., Chen, B.-Q., Wang, Y., Zhang, H., Kao, C., Sang, Q.A., Pathak, S.J. and Chung, W.K. (1996) Androgen-repressed phenotype in human prostate cancer. Proc. Natl Acad. Sci. USA, 93, 15152-15157.